Aris P. Agouridis

Rosuvastatin treatment is associated with an increase in insulin resistance in hyperlipidaemic patients with impaired fasting glucose

Michael S. Kostapanos, Haralambos Milionis, Aris P. Agouridis et al. · International Journal of Clinical Practice · 2009 · 54 citations

Medicine, Endocrinology, Pharmacotherapy +17

Ear lobe crease: a marker of coronary artery disease?

Aris P. Agouridis, Moses Elisaf, Devaki Nair et al. · Archives of Medical Science · 2015 · 39 citations · Full text

Medicine, Cardiology, Anterior Segment Disease +6

The effects of rosuvastatin alone or in combination with fenofibrate or omega 3 fatty acids on inflammation and oxidative stress in patients with mixed dyslipidemia

Aris P. Agouridis, Vasilis Tsimihodimos, Theodosios D. Filippatos et al. · Expert Opinion on Pharmacotherapy · 2011 · 33 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Effect of rosuvastatin monotherapy or in combination with fenofibrate or ω-3 fatty acids on lipoprotein subfraction profile in patients with mixed dyslipidaemia and metabolic syndrome

Aris P. Agouridis, Michael S. Kostapanos, Vasilis Tsimihodimos et al. · International Journal of Clinical Practice · 2012 · 25 citations

Life Sciences, Pharmacology, Pharmacotherapy +17

High Doses of Rosuvastatin are Superior to Low Doses of Rosuvastatin Plus Fenofibrate or n‐3 Fatty Acids in Mixed Dyslipidemia

Aris P. Agouridis, Vasilis Tsimihodimos, Theodosios D. Filippatos et al. · Lipids · 2011 · 23 citations

Pharmacy, Pharmacology, Pharmacotherapy +17